Low-dose DHEA treatment enhanced vascular endothelial functionality and insulin sensitivity while decreasing plasminogen activator inhibitor type 1 concentration in a randomized, double-blind investigation of men with hypercholesterolemia (28). The gene discussed is INS; the disease is familial hypercholesterolemia.